BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30964854)

  • 41. Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.
    Zhao N; Guo Y; Zhang M; Lin L; Zheng Z
    Oncol Rep; 2010 May; 23(5):1443-7. PubMed ID: 20372862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets.
    Dal Col J; Mastorci K; Faè DA; Muraro E; Martorelli D; Inghirami G; Dolcetti R
    Cancer Res; 2012 Apr; 72(7):1825-35. PubMed ID: 22311672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
    Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
    Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Curcumin nanodisk-induced apoptosis in mantle cell lymphoma.
    Singh AT; Ghosh M; Forte TM; Ryan RO; Gordon LI
    Leuk Lymphoma; 2011 Aug; 52(8):1537-43. PubMed ID: 21699455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.
    Saba NS; Liu D; Herman SE; Underbayev C; Tian X; Behrend D; Weniger MA; Skarzynski M; Gyamfi J; Fontan L; Melnick A; Grant C; Roschewski M; Navarro A; Beà S; Pittaluga S; Dunleavy K; Wilson WH; Wiestner A
    Blood; 2016 Jul; 128(1):82-92. PubMed ID: 27127301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PRDM1 is required for mantle cell lymphoma response to bortezomib.
    Desai S; Maurin M; Smith MA; Bolick SC; Dessureault S; Tao J; Sotomayor E; Wright KL
    Mol Cancer Res; 2010 Jun; 8(6):907-18. PubMed ID: 20530581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.
    Li Y; Bouchlaka MN; Wolff J; Grindle KM; Lu L; Qian S; Zhong X; Pflum N; Jobin P; Kahl BS; Eickhoff JC; Wuerzberger-Davis SM; Miyamoto S; Thomas CJ; Yang DT; Capitini CM; Rui L
    Oncogene; 2016 Dec; 35(48):6223-6234. PubMed ID: 27157620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
    Montraveta A; Xargay-Torrent S; Rosich L; López-Guerra M; Roldán J; Rodríguez V; Lee-Vergés E; de Frías M; Campàs C; Campo E; Roué G; Colomer D
    Oncotarget; 2015 Aug; 6(25):21159-72. PubMed ID: 26110568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The dual PI3K and mTOR inhibitor NVP-BEZ235 exhibits anti-proliferative activity and overcomes bortezomib resistance in mantle cell lymphoma cells.
    Kim A; Park S; Lee JE; Jang WS; Lee SJ; Kang HJ; Lee SS
    Leuk Res; 2012 Jul; 36(7):912-20. PubMed ID: 22560334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.
    Kagiyama Y; Fujita S; Shima Y; Yamagata K; Katsumoto T; Nakagawa M; Honma D; Adachi N; Araki K; Kato A; Inaki K; Ono Y; Fukuhara S; Kobayashi Y; Tobinai K; Kitabayashi I
    Cancer Sci; 2021 Jun; 112(6):2314-2324. PubMed ID: 33792119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reactive oxygen species mediate cancer stem-like cells and determine bortezomib sensitivity via Mcl-1 and Zeb-1 in mantle cell lymphoma.
    Luanpitpong S; Poohadsuan J; Samart P; Kiratipaiboon C; Rojanasakul Y; Issaragrisil S
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3739-3753. PubMed ID: 30251692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9.
    Georgakis GV; Li Y; Younes A
    Br J Haematol; 2006 Oct; 135(1):68-71. PubMed ID: 16925576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of silencing NOTCH1 gene by shRNA interference on AKT/mTOR pathway in mantle cell lymphoma].
    Huang YQ; Huang XL; Ma XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1616-20. PubMed ID: 25543484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered apoptosis pathways in mantle cell lymphoma.
    Rummel MJ; de Vos S; Hoelzer D; Koeffler HP; Hofmann WK
    Leuk Lymphoma; 2004 Jan; 45(1):49-54. PubMed ID: 15061196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway.
    Zheng J; Hu JD; Chen YY; Chen BY; Huang Y; Zheng ZH; Liu TB
    Asian Pac J Cancer Prev; 2012; 13(4):1119-24. PubMed ID: 22799292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
    Moosburner M; Alibegovic L; Hasselmann K; Gaiderov A; Hildebrand J; Philippou-Massier J; Blum H; Fischer L; Dreyling M; Silkenstedt E
    Hematol Oncol; 2023 Dec; 41(5):858-868. PubMed ID: 37300279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia.
    Nogami A; Oshikawa G; Okada K; Fukutake S; Umezawa Y; Nagao T; Kurosu T; Miura O
    Oncotarget; 2015 Apr; 6(11):9189-205. PubMed ID: 25826077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125.
    Wang M; Atayar C; Rosati S; Bosga-Bouwer A; Kluin P; Visser L
    J Pathol; 2009 May; 218(1):95-103. PubMed ID: 19206150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.
    Mastorci K; Muraro E; Pasini E; Furlan C; Sigalotti L; Cinco M; Dolcetti R; Fratta E
    PLoS One; 2016; 11(4):e0153823. PubMed ID: 27123851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
    Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
    PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.